MD-Ligand-Receptor:一种高性能计算工具,用于表征分子动力学轨迹中的联体受体结合相互作用
Michele Pieroni1, Francesco Madeddu1, Jessica Di Martino2
1Department of Computer Science, "Sapienza" University of Rome, V. le Regina Elena 295, 00161 Rome, Italy.
International journal of molecular sciences
|July 29, 2023
概括
分子动力学模拟软件MD-ligand-receptor (MDLR) 分析了随时间推移的动态药物受体相互作用. 这种工具揭示了长期的分子相互作用,并预测了药物疗效,超越静态分析以获得更深入的生物学见解.
科学领域:
- 计算生物学是一种计算生物学.
- 分子建模分子建模
- 药理学 药理学是指药理学的学科.
背景情况:
- 分子动力学 (MD) 模拟对于研究动态分子系统至关重要.
- 分析体受体结合相互作用 (lrbi) 需要理解动态的,时间依赖的行为.
- 现有的工具往往提供静态快照,限制了对长期互动的洞察力.
研究的目的:
- 介绍MD-ligand-receptor (MDLR),一种用于分析随时间推移的联体受体相互作用的新型软件.
- 能够研究动态分子行为和时间依赖的药物抑制活性.
- 为研究人员提供先进的工具来探索复杂的联结体-受体系统.
主要方法:
- 利用分子动力学轨迹来模拟和分析宏分子生物系统.
- 采用高性能计算管道,以高效地处理大型轨迹数据.
- 开发一个交互式 Python 笔记本 (Jupyter) 用于 lrbi. 的可视化和解释.
主要成果:
- 在静态分析之外,MDLR有效捕捉长期的分子相互作用.
- 该软件基于动态模拟来预测药物的依赖时间的抑制活性.
- 高性能计算优化允许对广泛的分子动态数据进行快速分析.
结论:
- 在理解动态体受体结合相互作用方面,MDLR提供了显著的进展.
- 该软件为药物受体系统的时间方面提供了有价值的见解.
- MDLR促进了复杂分子动态数据的高效探索和可视化,用于药物发现.
更多相关视频
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
97
09:15Measuring Biomolecular DSC Profiles with Thermolabile Ligands to Rapidly Characterize Folding and Binding Interactions
Published on: November 21, 2017
8.3K
相关概念视频
02:40Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
02:18The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
00:49Ligand Binding and Linkage
3.1K
3.1K
01:29The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K